Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
CYBX [NASD]
Cyberonics Inc.
Index- P/E31.25 EPS (ttm)1.65 Insider Own2.00% Shs Outstand27.57M Perf Week-0.67%
Market Cap1.42B Forward P/E22.62 EPS next Y2.28 Insider Trans-10.84% Shs Float26.73M Perf Month4.67%
Income46.40M PEG1.64 EPS next Q0.46 Inst Own91.90% Short Float10.58% Perf Quarter11.99%
Sales254.30M P/S5.59 EPS this Y29.70% Inst Trans12.00% Short Ratio7.68 Perf Half Y1.32%
Book/sh8.33 P/B6.19 EPS next Y15.62% ROA19.30% Target Price56.70 Perf Year23.05%
Cash/sh4.93 P/C10.47 EPS next 5Y19.00% ROE21.90% 52W Range42.25 - 56.73 Perf YTD-1.83%
Dividend- P/FCF22.01 EPS past 5Y44.30% ROI21.00% 52W High-9.10% Beta0.84
Dividend %- Quick Ratio6.50 Sales past 5Y16.00% Gross Margin91.40% 52W Low22.06% ATR1.35
Employees- Current Ratio7.20 Sales Q/Q18.60% Oper. Margin30.80% RSI (14)63.79 Volatility1.71% 2.64%
OptionableYes Debt/Eq0.02 EPS Q/Q7.90% Profit Margin18.20% Rel Volume0.57 Prev Close51.29
ShortableYes LT Debt/Eq0.02 EarningsJun 05 BMO Payout0.00% Avg Volume368.15K Price51.57
Recom1.50 SMA203.78% SMA5010.25% SMA2006.21% Volume210,636 Change0.55%
06-Jun-13Upgrade Northland Capital Under Perform → Market Perform $40 → $44
29-May-13Reiterated Canaccord Genuity Buy $59 → $49
25-Feb-13Reiterated Dougherty & Company Buy $56 → $58
18-Oct-12Initiated Northland Securities Under Perform $40
26-Sep-12Reiterated WBB Securities Strong Buy $60
29-Aug-12Upgrade Canaccord Genuity Hold → Buy $34 → $56
29-Aug-12Upgrade Canaccord Genuity Hold → Buy
09-Aug-12Initiated William Blair Outperform
03-Jan-12Upgrade Kaufman Bros Hold → Buy $28 → $38
03-Jun-11Upgrade WBB Securities Buy → Strong Buy
03-Jun-11Reiterated Canaccord Genuity Hold $30.50 → $26.50
31-Jan-11Reiterated WBB Securities Buy $22 → $38
04-Jan-11Initiated Jefferies Buy $37
20-Jul-10Initiated Dougherty & Company Buy $29
19-Feb-10Downgrade WBB Securities Strong Buy → Buy $17.50 → $22
04-Jan-10Upgrade Robert W. Baird Neutral → Outperform $17 → $25
01-Dec-09Initiated Robert W. Baird Neutral $17
20-Nov-09Upgrade Piper Jaffray Neutral → Overweight $20
18-Mar-09Reiterated Lazard Capital Mkts Buy $19 → $21
21-Nov-08Upgrade Piper Jaffray Neutral → Buy
14-Jun-13 01:02AM  Cyberonics: Making Bucks More Quickly at Motley Fool
10-Jun-13 01:20PM  St. Jude Expands Neuro Offerings Zacks
04:47AM  Bulls look for big rally in Cyberonics optionMONSTER
07-Jun-13 01:40PM  Quest and Hologic Extend Ties Zacks
11:04AM  Are These Wednesday Post-Earnings Movers a Buy? at Motley Fool
08:30AM  Accuray Expands in France Zacks
01:11AM  Why the Street Should Love Cyberonics's Earnings at Motley Fool
06-Jun-13 01:40PM  MDT Cease IN.PACT Admiral Enrollment Zacks
09:02AM  Company News for June 6, 2013 Zacks
08:40AM  CYBX Earnings Beat; Expects Strong FY14 Zacks
12:05AM  Cyberonics upgraded by Northland Capital Briefing.com
05-Jun-13 06:04PM  Nasdaq stocks posting largest percentage increases AP +5.24%
05:48PM  MDT's Catheter Gets Regulatory Approvals Zacks
05:16PM  Xerox, Dollar General, Audience are big movers AP
02:43PM  Hot Stocks: Monsanto Falls, Bed Bath & Beyond and Mattress Makers Rise at Barrons.com
02:30PM  ZMH Acquires NORMED Zacks
01:40PM  PerkinElmer Releases New Apps Zacks
12:40PM  Cyberonics Management Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
11:59AM  Cyberonics rises on fiscal 4Q results and outlook AP
11:53AM  CYBX Crosses Above Key Moving Average Level at Forbes
11:32AM  Cyberonics Stock Jumps On Strong Q4, Guidance at Investor's Business Daily
09:26AM  Morning MoneyBeat: Avalanche of Jobs Data on Tap at The Wall Street Journal
08:41AM  Morning MoneyBeat: Avalanche of Jobs Data on Tap at The Wall Street Journal
08:28AM  Morning MoneyBeat: Avalanche of Jobs Data on Tap at The Wall Street Journal
07:07AM  Q4 2013 Cyberonics Earnings Release - Before Market Open CCBN
07:00AM  Cyberonics Reports Record Quarter And Annual Results And Provides Fiscal 2014 Guidance PR Newswire
12:02AM  CYBERONICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04-Jun-13 03:55PM  BSX Funding for Women's Health Zacks
03:16PM  Notable companies reporting before tomorrow's open at theflyonthewall.com
02:20PM  Another Client Win for Omnicell Zacks
02:00PM  Twin Launch by ResMed Zacks
31-May-13 01:20PM  Luminex and Merck KGaA Extend Ties Zacks
30-May-13 01:40PM  Omnicare Unit Partners Drug Buster Zacks
08:40AM  Abiomed Gains Reimbursement Approval Zacks
29-May-13 06:31PM  4 Healthcare Stock Stories For Midweek Investment Wellness at Wall St. Cheat Sheet
02:10PM  Good News for HOLX after Weak 2Q13 Zacks
01:50PM  Setback for CYBX Ahead of 4Q13 Result Zacks
28-May-13 07:37PM  Medicare declines to cover Cyberonics' anti-depression device at Reuters
05:30PM  InPlay: Cyberonics recieves CMS letter declining the company's request to reconsider 2007 National Coverage Determination; announces response to submission for reconsideration of coverage of VNS Therapy in treatment-resistant depression Briefing.com
05:30PM  Cyberonics Announces Response To Submission For Reconsideration Of Coverage Of VNS Therapy® in Treatment-Resistant Depression PR Newswire
09:00AM  Cyberonics To Participate In Upcoming Investor Conferences PR Newswire
01:59AM  CYBERONICS INC Files SEC form 8-K, Other Events EDGAR Online
20-May-13 03:49PM  CYBX January 2014 Options Begin Trading at TheStreet
14-May-13 11:47AM  Bullish Two Hundred Day Moving Average Cross - CYBX at TheStreet
10-May-13 09:57AM  SPDR S&P Health Care Equipment ETF -- Insider Buying Index Registering 11.8% at Forbes
07-May-13 09:00AM  Cyberonics To Report Fourth Quarter And Fiscal Year 2013 Results And Host Webcast And Conference Call On June 5, 2013 PR Newswire
02-May-13 01:59PM  Seven shorts for a possible May pullback at MarketWatch
26-Apr-13 03:20PM  Earnings Beat for ABAX, Sluggish Overall Zacks
08:20AM  PerkinElmer Misses Earnings and Rev Est Zacks
25-Apr-13 03:20PM  BSX Beats Y/Y Earnings, Guides Low Zacks
01:50PM  OCR Beats on Earnings Est; Misses Rev Zacks
01:40PM  Varian Beats Earnings and Rev Est Zacks
24-Apr-13 12:05PM  TMO's Earnings Beat, LIFE Buyout on Track Zacks
08:00AM  AmSurg's Rev and Earnings In Line Zacks
23-Apr-13 03:00PM  Illumina Beats on Earnings, Revenue Zacks
22-Apr-13 01:40PM  Varian to Work with PSI on IMPT Zacks
19-Apr-13 02:20PM  Covidien Expands Shiley Offerings Zacks
01:40PM  FDA Nod for Luminex Offering Zacks
10:50AM  Cepheid Earnings Beat, Retains Outlook Zacks
10:45AM  LabCorp Earnings Misses Again Zacks
18-Apr-13 05:02PM  Healthcare-Focused Hedgie Bullish on These Stocks at Motley Fool
02:30PM  Myriad Downgraded to Neutral Zacks
02:20PM  Volcano Corporation Stays Neutral Zacks
01:40PM  Encouraging 4Q Prelims for Abiomed Zacks
17-Apr-13 02:35PM  More Backing for HOLX Tomosynthesis Zacks
02:32PM  3 longs and 3 shorts to watch at MarketWatch
02:15PM  Varian Applies Latest Vitesse Zacks
12:20PM  Another Earnings Miss for DGX Zacks
16-Apr-13 05:10PM  Covance Augments Singapore Facility Zacks
15-Apr-13 02:20PM  BSX Precision System Now in U.S. Zacks
02:10PM  Haemonetics Back to Neutral Zacks
12-Apr-13 01:50PM  Cyberonics Stands Out at Outperform Zacks
01:40PM  Thoratec Upgraded to Neutral Zacks
08:30AM  FDA Approves TFX's ISO-Gard Mask Zacks
11-Apr-13 02:10PM  Product Recall Plagues Integra Zacks
01:40PM  LIFE Takeover Battle Heats Up Zacks
10-Apr-13 04:31PM  BioScrip Raised to Outperform Zacks
04:30PM  Will Thermo Fisher Buy LIFE? Zacks
02:20PM  Merge Enhances eClinical OS Platform Zacks
01:50PM  New Bioinformatics Tools by LIFE Zacks
01:40PM  HMA Previews 1Q Earnings Results Zacks
08:40AM  Quest Closes HemoCue Divestment Zacks
09-Apr-13 01:50PM  Safeway's Blackhawk Settles IPO Price Zacks
01:40PM  Fresenius Teams with HCACO Zacks
08:10AM  ANGO Posts Dismal 3Q Earnings Zacks
08-Apr-13 02:30PM  CYBX Resumes Reimbursement Efforts Zacks
02:20PM  Another Adoption of Masimo Zacks
02:00PM  MDT to Grow Endovascular Biz Globally Zacks
01:50PM  Hologic Reiterated at Neutral Zacks
05-Apr-13 12:58PM  Medtronic Remains at Neutral Zacks
04-Apr-13 01:58PM  Boston Scientific Stays at Neutral Zacks
01:38PM  Mindray to Exhibit at CMEF Zacks
09:04AM  InPlay: Cyberonics has not received a formal response from CMS regarding reimbursement coverage for the treatment-resistant depression indication for the VNS Therapy System Briefing.com
09:00AM  Cyberonics Provides Update On Submission To CMS PR Newswire
03-Apr-13 04:03PM  LIFE Grows AmpliSeq Portfolio Zacks
01:18PM  FDA Clears Affinity, Boosts MDT's Biz Zacks
01:08PM  Is a Revenue Miss Coming for Cyberonics? at Motley Fool
08:08AM  Abiomed Begins Impella RP Trial Zacks
02-Apr-13 02:18PM  HMA Set to Start New JV Zacks
01:48PM  ResMed Protects Patent Landscape Zacks
Cyberonics, Inc. engages in the design, development, marketing, and sale of implantable medical devices. It offers vagus nerve stimulation therapy (VNS Therapy), a neuromodulation therapy for the treatment of refractory epilepsy and treatment-resistant depression, and other device solutions for the management of epilepsy. Its proprietary VNS Therapy System includes an implantable pulse generator to provide stimulation to the vagus nerve; a lead that connects the generator to the vagus nerve; equipment to assist with the implant procedure; equipment to assist the treating physician with setting the stimulation parameters for each patient; instruction manuals; and magnets to temporarily suspend or induce stimulation manually. The company sells its VNS Therapy System to hospitals and ambulatory surgery centers. It sells its products directly, as well as through independent distributors in Europe, Canada, Mexico, Australia, parts of Central and South America, the Middle East, China, Japan, and other parts of Asia. The company was founded in 1987 and is headquartered in Houston, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BROWNE GREGORY HSR VP Finance & CFOJun 17Option Exercise21.0514,926314,261117,007Jun 18 05:20 PM
Moore Daniel JeffreyPresident & CEOJun 17Option Exercise14.724,00058,880168,072Jun 18 05:24 PM
BROWNE GREGORY HSR VP Finance & CFOJun 17Sale51.6916,426848,997100,581Jun 18 05:20 PM
Moore Daniel JeffreyPresident & CEOJun 17Sale51.617,000361,243161,072Jun 18 05:24 PM
Olin Bryan DVP Clinical Quality RegulatoryJun 12Option Exercise14.727,000103,04070,886Jun 14 07:52 AM
Olin Bryan DVP Clinical Quality RegulatoryJun 12Sale52.307,000366,07763,886Jun 14 07:52 AM
Perkins Sherrie LVP, Mktg & NBDJun 07Option Exercise20.461,08522,19623,161Jun 11 03:33 PM
WISE DAVID SSR VP & Chief Admin OfficerJun 07Option Exercise19.755,00098,75099,882Jun 11 03:50 PM
Jackson Guy C.DirectorJun 07Option Exercise21.567,500161,70039,334Jun 11 03:07 PM
WISE DAVID SSR VP & Chief Admin OfficerJun 07Sale52.215,000261,07494,882Jun 11 03:50 PM
Perkins Sherrie LVP, Mktg & NBDJun 07Sale53.001,08557,50522,076Jun 11 03:33 PM
Novak Alfred JDirectorJun 07Sale52.497,213378,58319,896Jun 11 03:29 PM
Jackson Guy C.DirectorJun 07Sale51.757,500388,11131,834Jun 11 03:07 PM
Moore Daniel JeffreyPresident & CEOJun 05Sale49.863,000149,58725,086Jun 07 10:24 AM
WISE DAVID SSR VP & Chief Admin OfficerJun 03Sale47.442,00094,88094,882Jun 05 09:07 AM
Morris Milton MayoSR VP Research & DevelopmentMay 20Option Exercise16.385,00081,90058,009May 22 10:30 AM
Morris Milton MayoSR VP Research & DevelopmentMay 20Sale49.195,000245,93653,009May 22 10:30 AM
Moore Daniel JeffreyPresident & CEOMay 15Option Exercise19.544,00078,153159,757May 17 11:15 AM
Moore Daniel JeffreyPresident & CEOMay 15Sale48.167,000337,121152,757May 17 11:15 AM
Moore Daniel JeffreyPresident & CEOMay 06Sale43.033,000129,10426,586May 08 02:30 PM
Moore Daniel JeffreyPresident & CEOApr 15Option Exercise19.394,00077,560162,757Apr 17 11:48 AM
Moore Daniel JeffreyPresident & CEOApr 15Sale44.787,000313,476155,757Apr 17 11:48 AM
Moore Daniel JeffreyPresident & CEOApr 05Sale45.973,000137,91636,183Apr 09 02:25 PM
Moore Daniel JeffreyPresident & CEOMar 15Option Exercise19.394,00077,560174,190Mar 19 01:05 PM
Moore Daniel JeffreyPresident & CEOMar 15Sale46.557,000325,822167,190Mar 19 01:05 PM
Perkins Sherrie LVP, Mktg & NBDMar 07Option Exercise19.393,25063,01825,326Mar 11 10:55 AM
Perkins Sherrie LVP, Mktg & NBDMar 07Sale48.083,250156,25122,076Mar 11 10:55 AM
Jackson Guy C.DirectorMar 06Option Exercise21.567,500161,70039,334Mar 08 08:26 AM
Jackson Guy C.DirectorMar 06Sale48.337,500362,46731,834Mar 08 08:26 AM
Moore Daniel JeffreyPresident & CEOMar 05Sale47.853,000143,55439,183Mar 07 11:06 AM
WISE DAVID SSR VP & Chief Admin OfficerMar 01Sale45.182,00090,36096,882Mar 05 10:54 AM
Alch DarrenVP & Asst SecretaryMar 01Sale45.4150022,70519,176Mar 05 10:53 AM
MORRISON HUGH MDirectorFeb 26Sale46.3039418,24313,605Feb 28 12:11 PM
Moore Daniel JeffreyPresident & CEOFeb 15Option Exercise19.394,00077,560177,190Feb 19 05:15 PM
Moore Daniel JeffreyPresident & CEOFeb 15Sale45.377,000317,608170,190Feb 19 05:15 PM
Moore Daniel JeffreyPresident & CEOFeb 05Sale46.683,000140,03342,183Feb 07 12:07 PM
WISE DAVID SSR VP & Chief Admin OfficerFeb 01Sale43.402,00086,80098,882Feb 05 02:40 PM
Moore Daniel JeffreyPresident & CEOJan 15Buy19.394,00077,560180,190Jan 17 11:20 AM
Moore Daniel JeffreyPresident & CEOJan 15Sale52.727,000369,049173,190Jan 17 11:20 AM
Moore Daniel JeffreyPresident & CEOJan 07Sale52.893,000158,66345,183Jan 09 02:54 PM
WISE DAVID SSR VP & Chief Admin OfficerJan 02Sale53.522,000107,040100,882Jan 04 11:29 AM
Novak Alfred JDirectorDec 21Sale52.514,000210,03227,109Dec 26 07:10 PM
Olin Bryan DVP, QualityDec 18Buy24.819,505235,86673,391Dec 20 02:04 PM
MORRISON HUGH MDirectorDec 18Sale51.9280041,53313,999Dec 19 03:04 PM
Olin Bryan DVP, QualityDec 18Sale51.899,505493,19063,886Dec 20 02:04 PM
Moore Daniel JeffreyPresident & CEODec 17Buy19.394,00077,560183,190Dec 19 04:42 PM
Moore Daniel JeffreyPresident & CEODec 17Sale51.247,000358,652176,190Dec 19 04:42 PM
Perkins Sherrie LVP, Mktg & NBDDec 12Buy30.782,50076,95024,961Dec 14 11:27 AM
Perkins Sherrie LVP, Mktg & NBDDec 12Sale52.582,500131,45922,461Dec 14 11:27 AM
SIMPSON RANDAL LVP OperationsDec 06Buy19.7510,000197,50063,453Dec 10 12:30 PM
Morris Milton MayoSR VP Research & DevelopmentDec 06Sale52.003,615187,98753,009Dec 10 12:32 PM
SIMPSON RANDAL LVP OperationsDec 06Sale51.6516,000826,38247,453Dec 10 12:30 PM
Alch DarrenVP & Asst SecretaryDec 05Sale51.781,00051,78019,676Dec 07 12:13 PM
Moore Daniel JeffreyPresident & CEODec 05Sale51.843,000155,52948,183Dec 07 12:09 PM
BROWNE GREGORY HSR VP Finance & CFODec 04Buy22.9410,531241,597112,122Dec 06 01:03 PM
BROWNE GREGORY HSR VP Finance & CFODec 04Sale51.8810,531546,396101,591Dec 06 01:03 PM
WISE DAVID SSR VP & Chief Admin OfficerDec 03Sale51.762,000103,520102,882Dec 05 02:32 PM
ROSENTHAL ARTHUR LDirectorNov 29Sale51.925,052262,28310,496Dec 03 02:30 PM
Tremmel Jon TDirectorNov 27Sale52.391,40073,33913,663Nov 29 09:06 AM
Moore Daniel JeffreyPresident & CEONov 15Buy19.394,00077,560203,571Nov 19 04:18 PM
Moore Daniel JeffreyPresident & CEONov 15Sale46.417,000324,841196,571Nov 19 04:18 PM
Moore Daniel JeffreyPresident & CEONov 05Sale44.723,000134,15951,183Nov 07 04:38 PM
WISE DAVID SSR VP & Chief Admin OfficerNov 01Sale46.142,00092,280104,882Nov 05 02:14 PM
Moore Daniel JeffreyPresident & CEOOct 15Buy18.954,00075,785206,571Oct 17 03:48 PM
Moore Daniel JeffreyPresident & CEOOct 15Sale51.107,000357,728199,571Oct 17 03:48 PM
Moore Daniel JeffreyPresident & CEOOct 05Sale53.063,000159,18254,183Oct 09 04:34 PM
WISE DAVID SSR VP & Chief Admin OfficerOct 01Sale52.162,000104,320106,882Oct 02 05:34 PM
BROWNE GREGORY HSR VP Finance & CFOOct 01Sale52.162,500130,400101,591Oct 02 05:30 PM
BROWNE GREGORY HSR VP Finance & CFOSep 28Sale52.232,500130,575104,091Oct 02 05:30 PM
Verratti MarkVP Global SalesSep 27Buy37.9012,500473,75068,334Oct 01 03:20 PM
Verratti MarkVP Global SalesSep 27Sale52.5412,500656,77955,834Oct 01 03:20 PM
MORRISON HUGH MDirectorSep 24Sale52.434,828253,12214,799Sep 26 12:28 PM
Moore Daniel JeffreyPresident & CEOSep 17Buy14.724,00058,880209,571Sep 18 06:55 PM
Moore Daniel JeffreyPresident & CEOSep 17Sale50.457,000353,150202,571Sep 18 06:55 PM
Jackson Guy C.DirectorSep 14Buy21.565,000107,80035,405Sep 17 03:14 PM
BROWNE GREGORY HSR VP Finance & CFOSep 14Buy19.3910,000193,900116,591Sep 18 06:39 PM
BROWNE GREGORY HSR VP Finance & CFOSep 14Sale50.1210,000501,215106,591Sep 18 06:39 PM
Jackson Guy C.DirectorSep 14Sale50.415,000252,05030,405Sep 17 03:14 PM
Moore Daniel JeffreyPresident & CEOSep 05Sale51.023,000153,04857,183Sep 07 02:02 PM
WISE DAVID SSR VP & Chief Admin OfficerSep 04Sale50.032,000100,060108,882Sep 05 04:45 PM
BROWNE GREGORY HSR VP Finance & CFOSep 04Sale49.862,500124,650106,591Sep 05 04:37 PM
Olin Bryan DVP, QualityAug 30Buy14.7218,750276,00082,636Aug 31 03:12 PM
Olin Bryan DVP, QualityAug 30Sale49.4918,750927,90663,886Aug 31 03:12 PM
Moore Daniel JeffreyPresident & CEOAug 15Buy14.724,00058,880220,569Aug 17 12:00 PM
Moore Daniel JeffreyPresident & CEOAug 15Sale44.667,000312,589213,569Aug 17 12:00 PM
Moore Daniel JeffreyPresident & CEOAug 06Sale44.133,000132,40060,183Aug 08 05:26 PM
WISE DAVID SSR VP & Chief Admin OfficerAug 01Sale43.312,00086,620110,882Aug 03 10:56 AM
BROWNE GREGORY HSR VP Finance & CFOAug 01Sale43.312,500108,275109,091Aug 03 10:52 AM
Moore Daniel JeffreyPresident & CEOJul 16Buy14.724,00058,880209,199Jul 18 03:34 PM
Moore Daniel JeffreyPresident & CEOJul 16Sale43.717,000305,946202,199Jul 18 03:34 PM
Moore Daniel JeffreyPresident & CEOJul 05Sale46.653,000139,94063,183Jul 09 02:20 PM
WISE DAVID SSR VP & Chief Admin OfficerJul 02Sale44.622,00089,240112,882Jul 03 10:04 AM
BROWNE GREGORY HSR VP Finance & CFOJul 02Sale44.622,500111,550111,591Jul 03 09:59 AM
WISE DAVID SSR VP & Chief Admin OfficerJun 27Buy13.8829,500409,460144,382Jun 29 02:36 PM
WISE DAVID SSR VP & Chief Admin OfficerJun 27Sale44.7129,5001,319,036114,882Jun 29 02:36 PM
Morris Milton MayoVP Research & DevelopmentJun 26Sale45.0510,000450,50456,624Jun 27 05:27 PM
BROWNE GREGORY HSR VP Finance & CFOJun 26Sale45.4412,148551,965114,091Jun 27 05:20 PM
Reinstein James A.Former SR VPJun 22Sale44.2314,000619,2204,761Jun 26 08:10 PM
Reinstein James A.Former SR VPJun 22Sale44.1626511,70218,761Jun 25 09:36 AM
Reinstein James A.Former SR VPJun 21Sale43.7925,4001,112,29619,026Jun 25 09:36 AM